Kreck, Simon; Klaus, Jochen; Leidl, Reiner; von … - In: PharmacoEconomics 26 (2008) 4, pp. 311-328
Background: Osteoporosis is a frequent complication in patients with inflammatory bowel disease. Recent studies have shown bisphosphonates to considerably reduce fracture risk in patients with osteoporosis, and preventing fractures with bisphosphonates has been reported to be cost effective in...